Published on 29/12/2025
Using Rare Disease Day to Promote Clinical Trial Participation
What is Rare Disease Day and Why It Matters for Research
Rare Disease Day, observed annually on the last day of February, is a globally recognized event aimed at raising awareness for the 300+ million people living with rare diseases worldwide. Since its inception in 2008, it has grown into a powerful movement supported by patients, caregivers, healthcare providers, industry, and researchers across more than 100 countries.
For clinical trial sponsors, Rare Disease Day presents a unique and timely opportunity to educate the public about ongoing research, increase awareness of recruiting trials, and foster partnerships with advocacy organizations. By aligning recruitment efforts with this event, sponsors can elevate visibility, build trust, and drive engagement from the rare disease community.
Integrating Clinical Trial Messaging into Rare Disease Day Activities
While Rare Disease Day is not traditionally focused on clinical trials, its mission aligns perfectly with the goals of advancing treatment and innovation. Sponsors can incorporate trial messaging into RDD events and materials without overshadowing the advocacy agenda. Tactics include:
- Dedicated Web Pages: Create Rare Disease Day-branded landing pages highlighting currently enrolling studies.
- Social Media Integration: Use hashtags like
#RareDiseaseDay and #ShowYourRare in posts that link to trials on WHO ICTRP or sponsor websites.
These approaches ensure that trial promotion is informative, respectful, and community-aligned.
Designing Rare Disease Day Campaigns with Trial Awareness in Mind
A well-crafted Rare Disease Day campaign with trial-focused content requires strategic planning. Best practices include:
- Early Start: Begin planning 3–4 months ahead to secure partnerships, speaker availability, and regulatory approvals.
- Messaging Balance: Avoid overt trial recruitment appeals. Focus instead on education, empowerment, and the role of research in treatment advancement.
- Multichannel Presence: Use a mix of infographics, patient videos, email blasts, blog posts, and social engagement to reinforce messages.
- Branded Collateral: Develop Rare Disease Day-themed visuals such as posters, ribbons, and banners co-branded with trial sponsors or CROs (subject to IRB approval).
The goal is to generate interest and awareness that naturally leads patients and families to explore research participation options.
Collaborating with Advocacy Groups and Global Partners
Rare Disease Day is organized by EURORDIS and supported by a global alliance of patient organizations. Engaging with these partners can amplify your reach and improve community reception. Steps to consider:
- Reach out to national or regional advocacy groups well in advance.
- Offer content for their newsletters, blogs, or events highlighting the importance of research and participation.
- Invite advocacy leaders to join trial awareness panels or webinars.
- Provide IRB-approved educational materials for distribution at RDD events.
These collaborations not only strengthen messaging but also build credibility within the patient community.
Ethical and Regulatory Considerations
Even during awareness campaigns, sponsors must maintain compliance with ethical standards and regulations governing clinical trial promotion. Important guidelines include:
- IRB/Ethics Committee Review: Any trial-specific messaging, especially that includes calls to action, must be reviewed and approved.
- Transparent Disclosures: Make it clear when materials are sponsored and differentiate between education and promotion.
- Patient Privacy: Avoid collecting identifiable patient data during events without explicit informed consent.
- Local Laws: Follow all applicable rules for digital and physical advertising across countries where content will be distributed.
Partnering with legal and regulatory teams early in the campaign planning process ensures smooth approvals and message integrity.
Example: Trial Awareness Campaign Tied to Rare Disease Day
In 2023, a biotech company developing a treatment for a rare metabolic disorder launched a digital awareness campaign aligned with Rare Disease Day. Components included:
- A microsite with an animated explainer on clinical trials and a list of recruiting sites
- Two live patient panels hosted in collaboration with global advocacy groups
- Social media posts featuring caregivers sharing why research matters
- Newsletter inserts sent through advocacy group mailing lists
The campaign resulted in:
- 22,000 microsite visits in one week
- Over 400 pre-screening form completions
- 12 direct enrollments into the ongoing Phase II study
This case demonstrated that timing, empathy, and collaborative outreach can drive measurable recruitment outcomes.
Measuring Campaign Effectiveness
As with any awareness initiative, tracking and analysis are vital. Metrics to consider include:
- Reach and impressions across digital channels
- Engagement metrics (shares, comments, video views)
- Clicks and conversions to trial listing pages
- Referral sources for pre-screening form submissions
- Number of inquiries or calls to action completed during events
These insights help refine future campaigns and demonstrate ROI to stakeholders and internal teams.
Conclusion: Turning Awareness into Participation
Rare Disease Day offers more than symbolic solidarity—it is a strategic opportunity to connect awareness with action. Sponsors who engage ethically, collaborate meaningfully, and communicate clearly can transform this global event into a catalyst for recruitment success.
When awareness meets access, research becomes more inclusive, empowering the rare disease community not just to observe Rare Disease Day—but to shape its future.